Gene · 5394
Papers1,573
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,573
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comprehensive autoantibody profiling in systemic autoimmunity by a highly-sensitive multiplex protein array. | Front Immunol | 2023 | 37701440 | PubTator, text mining | PubMed |
| Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis-an exploratory study. | Arthritis Res Ther | 2023 | 37667402 | PubTator, text mining | PubMed |
| A systematic approach identifies p53-DREAM pathway target genes associated with blood or brain abnormalities. | Dis Model Mech | 2023 | 37661832 | PubTator, text mining | PubMed |
| Clinical and Serological Characteristics of a Monocentric Cohort of Patients Affected by Interstitial Pneumonia with Autoimmune Features (IPAF). | Mediterr J Rheumatol | 2023 | 37654644 | PubTator, text mining | PubMed |
| B Cell Lymphocytosis in Juvenile Dermatomyositis. | Diagnostics (Basel) | 2023 | 37627885 | PubTator, text mining | PubMed |
| Disturbed Antioxidant Capacity in Patients with Systemic Sclerosis Associates with Lung and Gastrointestinal Symptoms. | Biomedicines | 2023 | 37626607 | PubTator, text mining | PubMed |
| Anti-Ro52/Anti-nuclear Matrix Protein 2 Positive Clinically Amyopathic Dermatomyositis Presented Only With Interstitial Lung Disease. | Cureus | 2023 | 37602118 | PubTator, text mining | PubMed |
| Autoimmune Dysphagia Related to Rheumatologic Disorders: A Focused Review on Diagnosis and Treatment. | Cureus | 2023 | 37581141 | PubTator, text mining | PubMed |
| EP300 as a Molecular Integrator of Fibrotic Transcriptional Programs. | Int J Mol Sci | 2023 | 37569677 | PubTator, text mining | PubMed |
| R-loop-dependent promoter-proximal termination ensures genome stability. | Nature | 2023 | 37557913 | PubTator, text mining | PubMed |
| The PARN, TOE1, and USB1 RNA deadenylases and their roles in non-coding RNA regulation. | J Biol Chem | 2023 | 37544646 | PubTator, text mining | PubMed |
| Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort. | RMD Open | 2023 | 37541742 | PubTator, text mining | PubMed |
| Enhancer RNAs: mechanisms in transcriptional regulation and functions in diseases. | Cell Commun Signal | 2023 | 37537618 | PubTator, text mining | PubMed |
| Single-cell profiling of muscle-infiltrating T cells in idiopathic inflammatory myopathies. | EMBO Mol Med | 2023 | 37522383 | PubTator, text mining | PubMed |
| Unusual presentation of antisynthetase syndrome: a case series and review of the literature. | J Med Case Rep | 2023 | 37516893 | PubTator, text mining | PubMed |
| [18F]FDG-PET/CT in Idiopathic Inflammatory Myopathies: Retrospective Data from a Belgian Cohort. | Diagnostics (Basel) | 2023 | 37510060 | PubTator, text mining | PubMed |
| Anti-Cytosolic 5'-Nucleotidase 1A in the Diagnosis of Patients with Suspected Idiopathic Inflammatory Myopathies: An Italian Real-Life, Single-Centre Retrospective Study. | Biomedicines | 2023 | 37509600 | PubTator, text mining | PubMed |
| Mortality risk in patients with anti-MDA5 dermatomyositis is related to rapidly progressive interstitial lung disease and anti-Ro52 antibody. | Arthritis Res Ther | 2023 | 37488657 | PubTator, text mining | PubMed |
| Identification of lncRNAs Deregulated in Epithelial Ovarian Cancer Based on a Gene Expression Profiling Meta-Analysis. | Int J Mol Sci | 2023 | 37445988 | PubTator, text mining | PubMed |
| Pre-mRNA splicing order is predetermined and maintains splicing fidelity across multi-intronic transcripts. | Nat Struct Mol Biol | 2023 | 37443198 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5394/papers?page=6